- Home
- TOMZ vs COCP Comparison
TOMZ vs COCP Comparison
Compare TOMZ & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- COCP
- Stock Information
- Founded
- TOMZ 1979
- COCP 2006
- Country
- TOMZ United States
- COCP United States
- Employees
- TOMZ N/A
- COCP N/A
- Industry
- TOMZ Diversified Commercial Services
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- TOMZ Finance
- COCP Health Care
- Exchange
- TOMZ Nasdaq
- COCP Nasdaq
- Market Cap
- TOMZ 16.0M
- COCP 15.7M
- IPO Year
- TOMZ N/A
- COCP N/A
- Fundamental
- Price
- TOMZ $1.14
- COCP $1.65
- Analyst Decision
- TOMZ Strong Buy
- COCP Strong Buy
- Analyst Count
- TOMZ 1
- COCP 1
- Target Price
- TOMZ $3.50
- COCP $7.00
- AVG Volume (30 Days)
- TOMZ 32.9K
- COCP 27.2K
- Earning Date
- TOMZ 05-08-2025
- COCP 05-15-2025
- Dividend Yield
- TOMZ N/A
- COCP N/A
- EPS Growth
- TOMZ N/A
- COCP N/A
- EPS
- TOMZ N/A
- COCP N/A
- Revenue
- TOMZ $8,201,313.00
- COCP N/A
- Revenue This Year
- TOMZ $3.66
- COCP N/A
- Revenue Next Year
- TOMZ $139.63
- COCP N/A
- P/E Ratio
- TOMZ N/A
- COCP N/A
- Revenue Growth
- TOMZ 19.09
- COCP N/A
- 52 Week Low
- TOMZ $0.60
- COCP $1.12
- 52 Week High
- TOMZ $1.50
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- TOMZ 74.11
- COCP 56.83
- Support Level
- TOMZ $1.09
- COCP $1.40
- Resistance Level
- TOMZ $1.20
- COCP $1.75
- Average True Range (ATR)
- TOMZ 0.07
- COCP 0.14
- MACD
- TOMZ 0.04
- COCP 0.02
- Stochastic Oscillator
- TOMZ 90.88
- COCP 65.71
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).